COVID-VACCINATION

From NeuroRehab.wiki

Revision as of 09:56, 25 July 2023 by Dr Appukutty Manickam (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

SUMMARY

1. Past SARS-CoV-2 infection is not a contraindication to vaccination. People who have had COVID-19 are advised to receive the same number of COVID-19 vaccine doses as people who have never been infected.

2. People with SARS-CoV-2 infection can be vaccinated with their primary course of first booster when they have recovered following their confirmed infection or can defer for up to 4 months after the onset of the infection.

3. Those who have received monoclonal antibody treatment (Sotrovimab) or convalescent plasma should defer future doses of COVID-19 vaccine for at least 90 days.

4. Allowing a longer interval between recovery and vaccination may enhance the immune response to vaccination. Deferring vaccination after infection may also reduce the risk of misattribution of post-vaccination side effects to symptoms from post-COVID-19.

5. However, do not delay as vaccination boosts antibody levels & cell-mediated responses, reduces the risk of hospitalization.


Reference(s)

Cifu, D.X. (2020). Braddom’s physical medicine and rehabilitation. Elsevier. Get it on Amazon.
Cuccurullo, S. (2019). Physical medicine and rehabilitation board review. New York: Demosmedical. Get it on Amazon.
O’Young, B., Young, M.A. and Stiens, S.A. (2008). Physical Medicine and Rehabilitation Secrets. Mosby. Get it on Amazon.